Daiken Medical Co., Ltd. (TYO:7775)

Daiken Medical Income Statement

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Revenue	10,094	9,951	9,750	9,137	8,540	7,861
Revenue Growth (YoY)	2.58%	2.06%	6.71%	6.99%	8.64%	-7.77%
Cost of Revenue	6,108	5,855	5,768	5,607	4,856	4,503
Gross Profit	3,986	4,096	3,982	3,530	3,684	3,358
Selling, General & Admin	2,260	2,209	2,240	2,105	2,092	1,943
Research & Development	332	332	249	316	382	448
Operating Expenses	2,635	2,584	2,539	2,475	2,533	2,437
Operating Income	1,351	1,512	1,443	1,055	1,151	921
Interest Expense	-11	-9	-4	-3	-3	-3
Currency Exchange Gain (Loss)	1	-	2	-	1	-
Other Non Operating Income (Expenses)	6	6	5	-	3	38
EBT Excluding Unusual Items	1,347	1,509	1,446	1,052	1,152	956
Gain (Loss) on Sale of Assets	-	-	2	-	-	-
Asset Writedown	-2	-2	-5	-28	-1	-
Other Unusual Items	-	-	-8	-	-	-12
Pretax Income	1,345	1,507	1,435	1,024	1,151	944
Income Tax Expense	345	410	447	312	320	269
Net Income	1,000	1,097	988	712	831	675
Net Income to Common	1,000	1,097	988	712	831	675
Net Income Growth	-5.57%	11.03%	38.76%	-14.32%	23.11%	-21.42%
Shares Outstanding (Basic)	29	29	29	29	29	29
Shares Outstanding (Diluted)	29	29	29	29	29	29
EPS (Basic)	34.81	38.19	34.39	24.78	28.93	23.50
EPS (Diluted)	34.81	38.19	34.39	24.78	28.93	23.50
EPS Growth	-5.57%	11.03%	38.76%	-14.32%	23.11%	-21.42%
Free Cash Flow	626	954	1,393	791	931	300
Free Cash Flow Per Share	21.79	33.21	48.49	27.53	32.41	10.44
Gross Margin	39.49%	41.16%	40.84%	38.63%	43.14%	42.72%
Operating Margin	13.38%	15.19%	14.80%	11.55%	13.48%	11.72%
Profit Margin	9.91%	11.02%	10.13%	7.79%	9.73%	8.59%
Free Cash Flow Margin	6.20%	9.59%	14.29%	8.66%	10.90%	3.82%
EBITDA	1,594	1,744	1,657	1,322	1,465	1,177
EBITDA Margin	15.79%	17.53%	16.99%	14.47%	17.15%	14.97%
D&A For EBITDA	243	232	214	267	314	256
EBIT	1,351	1,512	1,443	1,055	1,151	921
EBIT Margin	13.38%	15.19%	14.80%	11.55%	13.48%	11.72%
Effective Tax Rate	25.65%	27.21%	31.15%	30.47%	27.80%	28.50%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.